Long-term survival with stereotactic radiosurgery and 100+ cycles of Keytruda in a patient with brain metastases from melanoma - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Sustained Survival in a Melanoma Patient with Brain Metastases Treated with Stereotactic Radiosurgery and Over 100 Doses of Keytruda

  • By

  • Darrah Sheehan

  • Kimball Sheehan

  • Yuki Shinya

  • Camilo E. Fadul

  • June 18, 2026

Share

Original Source(s)

Long-term survival with stereotactic radiosurgery and 100+ cycles of Keytruda in a patient with brain metastases from melanoma

  • by Darrah Sheehan, Kimball Sheehan, Yuki Shinya, Camilo E. Fadul

  • June 18, 2026

Related Content

Correction: Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases

  • August 1, 2026

Troponin Screening and Major Cardiovascular Adverse Events During Immune Checkpoint Inhibitor Therapy

Non-anticoagulant heparins: glycan-mediated immune modulation and therapeutic applications